These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8793853

  • 1. Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA.
    Lundholt BK, Madsen MW, Lykkesfeldt AE, Petersen OW, Briand P.
    Mol Cell Endocrinol; 1996 May 17; 119(1):47-59. PubMed ID: 8793853
    [Abstract] [Full Text] [Related]

  • 2. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA, Sager R, Webster L.
    Cancer Res; 1993 Oct 15; 53(20):5004-11. PubMed ID: 8402691
    [Abstract] [Full Text] [Related]

  • 3. Growth response of breast epithelial cells to estrogen is influenced by EGF.
    Briand P, Lundholt BK, Skouv J, Lykkesfeldt AE.
    Mol Cell Endocrinol; 1999 Jul 20; 153(1-2):1-9. PubMed ID: 10459848
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6.
    Pilat MJ, Christman JK, Brooks SC.
    Breast Cancer Res Treat; 1996 Jul 20; 37(3):253-66. PubMed ID: 8825137
    [Abstract] [Full Text] [Related]

  • 5. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA, Sager R.
    Mol Endocrinol; 1991 Nov 20; 5(11):1613-23. PubMed ID: 1664044
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways.
    Lundholt BK, Briand P, Lykkesfeldt AE.
    Breast Cancer Res Treat; 2001 Jun 20; 67(3):199-214. PubMed ID: 11561766
    [Abstract] [Full Text] [Related]

  • 7. Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor.
    Garcia M, Derocq D, Platet N, Bonnet S, Brouillet JP, Touitou I, Rochefort H.
    J Steroid Biochem Mol Biol; 1997 Apr 20; 61(1-2):11-7. PubMed ID: 9328205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor.
    Zajchowski DA, Webster L, Humm R, White FA, Simmons SJ, Bartholdi M.
    J Steroid Biochem Mol Biol; 1997 Aug 20; 62(5-6):373-83. PubMed ID: 9449240
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor.
    Jiang SY, Jordan VC.
    J Natl Cancer Inst; 1992 Apr 15; 84(8):580-91. PubMed ID: 1556769
    [Abstract] [Full Text] [Related]

  • 13. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
    Levenson AS, Gehm BD, Pearce ST, Horiguchi J, Simons LA, Ward JE, Jameson JL, Jordan VC.
    Int J Cancer; 2003 May 01; 104(5):587-96. PubMed ID: 12594813
    [Abstract] [Full Text] [Related]

  • 14. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
    Huo B, Dossing DA, Dimuzio MT.
    J Bone Miner Res; 1995 May 01; 10(5):769-81. PubMed ID: 7639112
    [Abstract] [Full Text] [Related]

  • 15. Stable transfection of the estrogen receptor cDNA into Hela cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth.
    Touitou I, Mathieu M, Rochefort H.
    Biochem Biophys Res Commun; 1990 May 31; 169(1):109-15. PubMed ID: 2350335
    [Abstract] [Full Text] [Related]

  • 16. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation.
    Erenburg I, Schachter B, Mira y Lopez R, Ossowski L.
    Mol Endocrinol; 1997 Dec 31; 11(13):2004-15. PubMed ID: 9415404
    [Abstract] [Full Text] [Related]

  • 17. Induction of p21 (CIP1/WAF1/SID1) by estradiol in a breast epithelial cell line transfected with the recombinant estrogen receptor gene: a possible mechanism for a negative regulatory role of estradiol.
    Thomas TJ, Faaland CA, Adhikarakunnathu S, Watkins LF, Thomas T.
    Breast Cancer Res Treat; 1998 Jan 31; 47(2):181-93. PubMed ID: 9497106
    [Abstract] [Full Text] [Related]

  • 18. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H.
    C R Seances Soc Biol Fil; 1998 Jan 31; 192(2):241-51. PubMed ID: 9841098
    [Abstract] [Full Text] [Related]

  • 19. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD, Greene GL, Katzenellenbogen BS.
    Mol Endocrinol; 1989 Feb 31; 3(2):295-304. PubMed ID: 2785242
    [Abstract] [Full Text] [Related]

  • 20. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.